GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human MTH1 in complex with inhibitor 7-(furan-2- yl)-5-methyl-1,3-benzoxazol-2-amine

Analyse Crystal structure of human MTH1 in complex with inhibitor 7-(furan-2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5NGT
Type
protein
Length
154 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
7,8-dihydro-8-oxoguanine triphosphatase
EC
3.6.1.55, 3.6.1.56
UniProt
P36639
Ligands
8WZ, SO4
Pockets
2 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 18% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A7,8-dihydro-8-oxoguanine triphosphatase (EC 3.6.1.55, 3.6.1.56)protein15418% helix, 47% strandP36639

Ligands and binding sites

  • 8WZ · 7-(furan-2-yl)-5-methyl-1,3-benzoxazol-2-amine · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11990.730.89318WZ
2550.320.7715empty

Compared structures

  • 5NGT · Crystal structure of human MTH1 in complex with inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00
  • P36639 · AlphaFold monomer V2.0 prediction for 7,8-dihydro-8-oxoguanine triphosphatase (P36639) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.